© 2000 European Society of Cardiology
Regional pre- and postsynaptic sympathetic system in the failing human heart — regulation of βARK-1
a Medizinische Klinik der Technischen Universität München, Klinikum rechts der Isar Ismaningerstr. 22, 81675 Munich, Germany
b Herzchirurgie, Deutsches Herzzentrum, Technische Universität München Munich, Germany
c Nuklearmedizinische Klinik, Technische Universität München Munich, Germany
* Corresponding author. Tel.: +49-89-4140-2947; fax: +49-89-4140-4901.E-mail address: ungerer{at}med1.med.tu-muenchen.de
 |
Abstract |
|---|
Objectives: Regional presynaptic sympathetic innervation varies considerably in the cardiomyopathic human heart, as shown in previous studies in vivo and in vitro. The goal of the present study was to correlate markers of presynaptic sympathetic innervation with local measurement of the postsynaptic β-adrenergic system in failing human hearts.
Methods and results: In nine left ventricular regions of hearts explanted from patients suffering from dilated cardiomyopathy, we measured the density of uptake1 carriers ([3H]mazindol binding) as a marker of presynaptic function as well as β-receptor density ([3H]CGP 12177 binding) and βARK-1 levels as the pivotal compounds of postsynaptic adrenergic signal transduction. Additionally, a subgroup of the patients was examined in vivo by HED-PET prior to heart transplantation. The density of uptake1 was related to local hydroxyephedrine (HED) retention (as determined by pre-operative PET, r=0.65), whereas it was inversely correlated to regional βARK-1 levels (r=–0.61, P=0.04). In contrast, β-adrenergic receptor density was not significantly correlated either to uptake1 density or to local HED retention (r=0.15 and r=0.21).
Conclusions: Regional βARK-1 levels rather than β-adrenergic receptor density were correlated with presynaptic alterations in cardiomyopathic human left ventricles. It can be assumed that in the cardiomyopathic human heart, regional β-adrenergic desensitization might be determined by differences in local βARK levels rather than by changes in β-receptor density.
Key Words: Heart failure • β-Receptors • β-Adrenergic receptor kinase-1
Received April 19, 1999; Revised November 1, 1999; Accepted December 1, 1999
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C. Kusmic, S. Morbelli, C. Marini, M. Matteucci, C. Cappellini, E. Pomposelli, P. Marzullo, A. L'Abbate, and G. Sambuceti Whole-Body Evaluation of MIBG Tissue Extraction in a Mouse Model of Long-Lasting Type II Diabetes and Its Relationship with Norepinephrine Transport Protein Concentration J. Nucl. Med., October 1, 2008; 49(10): 1701 - 1706. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. Burniston, L.-B. Tan, and D. F. Goldspink {beta}2-Adrenergic receptor stimulation in vivo induces apoptosis in the rat heart and soleus muscle J Appl Physiol, April 1, 2005; 98(4): 1379 - 1386. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Luss, M. Schafers, J. Neumann, D. Hammel, C. Vahlhaus, H. A Baba, F. Janssen, H. H Scheld, O. Schober, G. Breithardt, et al. Biochemical mechanisms of hibernation and stunning in the human heart Cardiovasc Res, December 1, 2002; 56(3): 411 - 421. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L'Abbate and G. Sambuceti Studying the neuronal side of the synaptic cleft. A tool for investigating the paradox of sympathetic nervous system and heart failure in dilated cardiomyopathy Eur. Heart J., September 1, 2001; 22(17): 1521 - 1522. [PDF]
|
|